128 related articles for article (PubMed ID: 36921302)
21. BRAF V600 mutation detection in melanoma: a comparison of two laboratory testing methods.
O'Brien O; Lyons T; Murphy S; Feeley L; Power D; Heffron CCBB
J Clin Pathol; 2017 Nov; 70(11):935-940. PubMed ID: 28424234
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of exon 15 BRAF mutations in primary melanoma of the superficial spreading, nodular, acral, and lentigo maligna subtypes.
Lang J; MacKie RM
J Invest Dermatol; 2005 Sep; 125(3):575-9. PubMed ID: 16117801
[TBL] [Abstract][Full Text] [Related]
23. MAP kinase activity supported by BRAF (V600E) mutation rather than gene amplification is associated with ETV1 expression in melanoma brain metastases.
Birner P; Berghoff AS; Dinhof C; Pirker C; Capper D; Schoppmann SF; Petzelbauer P; von Deimling A; Berger W; Preusser M
Arch Dermatol Res; 2014 Dec; 306(10):873-84. PubMed ID: 25073704
[TBL] [Abstract][Full Text] [Related]
24. Comparison of 2 monoclonal antibodies for immunohistochemical detection of BRAF V600E mutation in malignant melanoma, pulmonary carcinoma, gastrointestinal carcinoma, thyroid carcinoma, and gliomas.
Routhier CA; Mochel MC; Lynch K; Dias-Santagata D; Louis DN; Hoang MP
Hum Pathol; 2013 Nov; 44(11):2563-70. PubMed ID: 24071017
[TBL] [Abstract][Full Text] [Related]
25. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.
Larsen AC
Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168
[TBL] [Abstract][Full Text] [Related]
26. Three cases of
Cilento MA; Kim C; Chang S; Farshid G; Brown MP
Pathologica; 2022 Jun; 114(3):217-220. PubMed ID: 35775707
[TBL] [Abstract][Full Text] [Related]
27. Primary Noncutaneous Malignant Melanoma of the Breast.
Rassouli M; Voutsadakis IA
Breast J; 2016 Nov; 22(6):688-691. PubMed ID: 27488963
[TBL] [Abstract][Full Text] [Related]
28. Response to targeted therapy in two patients with metastatic melanoma carrying rare BRAF exon 15 mutations: A598_T599insV and V600_K601delinsE.
Rogiers A; Vander Borght S; Tuand K; Wolter P; Stas M; Boecxstaens V; Garmyn M; van den Oord JJ; Vandenberghe P; Bechter O
Melanoma Res; 2017 Oct; 27(5):507-510. PubMed ID: 28800030
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological characteristics and mutation profiling in primary cutaneous melanoma.
Yaman B; Akalin T; Kandiloğlu G
Am J Dermatopathol; 2015 May; 37(5):389-97. PubMed ID: 25357015
[TBL] [Abstract][Full Text] [Related]
30. Russian study of morphological prognostic factors characterization in BRAF-mutant cutaneous melanoma.
Aksenenko MB; Kirichenko AK; Ruksha TG
Pathol Res Pract; 2015 Jul; 211(7):521-7. PubMed ID: 25888143
[TBL] [Abstract][Full Text] [Related]
31. Molecular platforms utilized to detect BRAF V600E mutation in melanoma.
Curry JL; Torres-Cabala CA; Tetzlaff MT; Bowman C; Prieto VG
Semin Cutan Med Surg; 2012 Dec; 31(4):267-73. PubMed ID: 23174497
[TBL] [Abstract][Full Text] [Related]
32. Allele frequencies of BRAFV600 mutations in primary melanomas and matched metastases and their relevance for BRAF inhibitor therapy in metastatic melanoma.
Satzger I; Marks L; Kerick M; Klages S; Berking C; Herbst R; Völker B; Schacht V; Timmermann B; Gutzmer R
Oncotarget; 2015 Nov; 6(35):37895-905. PubMed ID: 26498143
[TBL] [Abstract][Full Text] [Related]
33. Dermoscopy and confocal microscopy for metachronous multiple melanomas: morphological, clinical, and molecular correlations.
Colombino M; Paliogiannis P; Pagliarello C; Cossu A; Lissia A; Satta R; Mazzoni L; Magi S; Sini MC; Manca A; Casula M; Doneddu V; Palmieri G; Stanganelli I
Eur J Dermatol; 2018 Apr; 28(2):149-156. PubMed ID: 29180316
[TBL] [Abstract][Full Text] [Related]
34. Pleural metastasis from auricular melanoma: A brief report.
Straccia P; Martini M; Pierconti F
Diagn Cytopathol; 2020 Apr; 48(4):376-379. PubMed ID: 31846216
[TBL] [Abstract][Full Text] [Related]
35. BRAF V600 mutations and pathological features in Japanese melanoma patients.
Yamazaki N; Tanaka R; Tsutsumida A; Namikawa K; Eguchi H; Omata W; Oashi K; Ogawa T; Hayashi A; Nakamura N; Tsuta K
Melanoma Res; 2015 Feb; 25(1):9-14. PubMed ID: 25051202
[TBL] [Abstract][Full Text] [Related]
36. Discordancy in BRAF mutations among primary and metastatic melanoma lesions: clinical implications for targeted therapy.
Bradish JR; Richey JD; Post KM; Meehan K; Sen JD; Malek AJ; Katona TM; Warren S; Logan TF; Fecher LA; Cheng L
Mod Pathol; 2015 Apr; 28(4):480-6. PubMed ID: 25376477
[TBL] [Abstract][Full Text] [Related]
37. Comparative study on driver mutations in primary and metastatic melanomas at a single Japanese institute: A clue for intra- and inter-tumor heterogeneity.
Kaji T; Yamasaki O; Takata M; Otsuka M; Hamada T; Morizane S; Asagoe K; Yanai H; Hirai Y; Umemura H; Iwatsuki K
J Dermatol Sci; 2017 Jan; 85(1):51-57. PubMed ID: 27771229
[TBL] [Abstract][Full Text] [Related]
38. Amelanotic Malignant Melanoma with a BRAF V600E Mutation Mimicking Primary Lung Cancer.
Matsuzawa R; Morise M; Tanaka I; Hayai S; Tamiya Y; Koyama J; Hase T; Wakahara K; Kim D; Shimoyama Y; Hashimoto N
Intern Med; 2022 Mar; 61(5):703-708. PubMed ID: 34433708
[TBL] [Abstract][Full Text] [Related]
39. Molecular evaluation of BRAF V600 mutation and its association with clinicopathological characteristics: First findings from Indian malignant melanoma patients.
Ahmad F; Avabhrath N; Natarajan S; Parikh J; Patole K; Das BR
Cancer Genet; 2019 Feb; 231-232():46-53. PubMed ID: 30803557
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemistry with a mutation-specific monoclonal antibody as a screening tool for the BRAFV600E mutational status in primary cutaneous malignant melanoma.
Feller JK; Yang S; Mahalingam M
Mod Pathol; 2013 Mar; 26(3):414-20. PubMed ID: 23041829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
